Neogen's Food Safety Division led the company's first quarter revenue increase, with a broad-based organic sales increase of over 20% from $11,392,000 in FY 2007 to $13,759,000 in FY 2008. Sales of Neogen's histamine test to the tuna industry increased by more than 20% after the test received an official approval from AOAC, an important third-party verification process for diagnostic test kits. Sales of Neogen's line of tests to detect foodborne pathogens, including E. coli O157:H7, Salmonella, and Listeria, continued their resurgence, with sales up 16% over the prior year's comparable quarter. Neogen's AccuPoint(R) line of general sanitation testing products continued to see advancing market acceptance, with strong double-digit increases on a year- to-year sales comparison.
Sales of Neogen's Soleris(TM) general microbial detection system, which was acquired mid-year in FY 2006, more than doubled in the first quarter of FY 2008 compared to the prior year's quarter. This significant increase was due in part to expanding applications of the technology, and increasing sales to international markets. Neogen Europe's sales, which represent a combination of sales of Neogen products produced in the U.S. and diagnostics manufactured in Scotland, increased 32% in FY 2008 over the prior year's first three months.
Led by Neogen Europe's performance, and an increase in sales of
rodenticides to the international market, the percentage of overall sales
from international markets reached 40% of Neogen's total revenues for the
first time ever. Strong sales of rodenticides outside of the United States
were led by a large increase in sales to Mexico, and product registrations
in a growing n
|SOURCE Neogen Corporation|
Copyright©2007 PR Newswire.
All rights reserved